| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| tau Proteins | 41 | 2024 | 2085 | 3.740 |
Why?
|
| Cerebral Amyloid Angiopathy | 43 | 2023 | 892 | 3.670 |
Why?
|
| Amyloid beta-Peptides | 74 | 2024 | 3832 | 3.660 |
Why?
|
| Alzheimer Disease | 112 | 2024 | 8547 | 3.620 |
Why?
|
| Tauopathies | 14 | 2024 | 317 | 2.720 |
Why?
|
| Brain | 128 | 2024 | 26951 | 2.480 |
Why?
|
| Neurofibrillary Tangles | 21 | 2022 | 457 | 1.960 |
Why?
|
| Plaque, Amyloid | 27 | 2022 | 758 | 1.630 |
Why?
|
| Temporal Lobe | 14 | 2018 | 1688 | 1.440 |
Why?
|
| Frontotemporal Lobar Degeneration | 9 | 2022 | 102 | 1.320 |
Why?
|
| Pick Disease of the Brain | 4 | 2024 | 42 | 1.200 |
Why?
|
| Neurons | 44 | 2024 | 9426 | 1.180 |
Why?
|
| Cerebral Hemorrhage | 22 | 2023 | 2660 | 1.160 |
Why?
|
| Neisseria meningitidis | 10 | 2001 | 107 | 0.970 |
Why?
|
| Proteostasis Deficiencies | 3 | 2020 | 39 | 0.970 |
Why?
|
| alpha-Synuclein | 14 | 2024 | 749 | 0.960 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2024 | 1846 | 0.920 |
Why?
|
| Neurodegenerative Diseases | 8 | 2024 | 1084 | 0.910 |
Why?
|
| Presenilin-1 | 14 | 2021 | 660 | 0.890 |
Why?
|
| Carbolines | 8 | 2024 | 288 | 0.890 |
Why?
|
| Cerebral Infarction | 8 | 2020 | 982 | 0.840 |
Why?
|
| Autopsy | 18 | 2022 | 1007 | 0.820 |
Why?
|
| Amyloid beta-Protein Precursor | 17 | 2018 | 1110 | 0.820 |
Why?
|
| Headache | 6 | 2024 | 1249 | 0.790 |
Why?
|
| Personality Disorders | 2 | 2024 | 721 | 0.760 |
Why?
|
| Cerebral Cortex | 21 | 2024 | 5761 | 0.740 |
Why?
|
| Sterilization | 1 | 2021 | 130 | 0.730 |
Why?
|
| Fatal Outcome | 16 | 2020 | 1832 | 0.730 |
Why?
|
| Multiple System Atrophy | 4 | 2022 | 129 | 0.730 |
Why?
|
| Peptide Fragments | 18 | 2021 | 5125 | 0.720 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2021 | 125 | 0.680 |
Why?
|
| Lewy Body Disease | 11 | 2019 | 252 | 0.670 |
Why?
|
| Magnetic Resonance Imaging | 66 | 2024 | 36290 | 0.670 |
Why?
|
| Astrocytoma | 2 | 2023 | 775 | 0.670 |
Why?
|
| Frontal Lobe | 6 | 2015 | 1420 | 0.640 |
Why?
|
| Humans | 337 | 2024 | 760621 | 0.620 |
Why?
|
| Brain Neoplasms | 16 | 2024 | 8986 | 0.610 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2021 | 299 | 0.600 |
Why?
|
| Diagnosis, Differential | 25 | 2024 | 12965 | 0.600 |
Why?
|
| Fatigue | 2 | 2024 | 1544 | 0.590 |
Why?
|
| Microglia | 12 | 2024 | 1351 | 0.590 |
Why?
|
| Aged, 80 and over | 92 | 2024 | 58995 | 0.580 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2024 | 929 | 0.570 |
Why?
|
| Hippocampus | 15 | 2024 | 3738 | 0.560 |
Why?
|
| Entorhinal Cortex | 7 | 2024 | 286 | 0.560 |
Why?
|
| Amyloid | 11 | 2023 | 842 | 0.550 |
Why?
|
| Mice, Transgenic | 41 | 2021 | 9530 | 0.550 |
Why?
|
| Glioma | 9 | 2023 | 3420 | 0.540 |
Why?
|
| Echinococcus | 5 | 2000 | 16 | 0.520 |
Why?
|
| Mutation | 40 | 2024 | 29932 | 0.520 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2017 | 83 | 0.520 |
Why?
|
| Parkinson Disease | 13 | 2022 | 2859 | 0.520 |
Why?
|
| Spinal Cord Neoplasms | 4 | 2023 | 264 | 0.510 |
Why?
|
| Aged | 132 | 2024 | 169152 | 0.500 |
Why?
|
| Prions | 3 | 2024 | 179 | 0.500 |
Why?
|
| Adrenoleukodystrophy | 4 | 2023 | 143 | 0.500 |
Why?
|
| Male | 195 | 2024 | 359744 | 0.500 |
Why?
|
| Cognition Disorders | 10 | 2019 | 3976 | 0.490 |
Why?
|
| Paresis | 3 | 2023 | 177 | 0.490 |
Why?
|
| Synapses | 9 | 2023 | 1757 | 0.480 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2014 | 17 | 0.470 |
Why?
|
| Tay-Sachs Disease | 1 | 2014 | 20 | 0.470 |
Why?
|
| Female | 184 | 2024 | 391270 | 0.460 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2024 | 99 | 0.420 |
Why?
|
| Diplopia | 1 | 2014 | 215 | 0.420 |
Why?
|
| Vasculitis, Central Nervous System | 4 | 2016 | 45 | 0.410 |
Why?
|
| Frontotemporal Dementia | 3 | 2022 | 246 | 0.400 |
Why?
|
| Helminth Proteins | 3 | 2000 | 172 | 0.400 |
Why?
|
| Autoradiography | 6 | 2019 | 730 | 0.400 |
Why?
|
| Radiopharmaceuticals | 9 | 2019 | 2634 | 0.400 |
Why?
|
| Animals | 113 | 2024 | 167963 | 0.400 |
Why?
|
| Epidermolysis Bullosa | 1 | 2011 | 29 | 0.400 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 908 | 0.390 |
Why?
|
| Meningococcal Infections | 3 | 2001 | 78 | 0.390 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 521 | 0.390 |
Why?
|
| Dementia | 10 | 2019 | 2649 | 0.380 |
Why?
|
| Microvessels | 4 | 2021 | 572 | 0.380 |
Why?
|
| Multiple Sclerosis | 2 | 2021 | 3204 | 0.380 |
Why?
|
| Middle Aged | 106 | 2024 | 220352 | 0.380 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2019 | 137 | 0.380 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2011 | 61 | 0.370 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2014 | 225 | 0.370 |
Why?
|
| Mice | 72 | 2024 | 81208 | 0.360 |
Why?
|
| Sarcoidosis | 1 | 2016 | 520 | 0.360 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2016 | 2125 | 0.360 |
Why?
|
| Isoquinolines | 2 | 2024 | 353 | 0.350 |
Why?
|
| Fusobacterium Infections | 1 | 2010 | 53 | 0.340 |
Why?
|
| Pyramidal Cells | 3 | 2024 | 369 | 0.340 |
Why?
|
| Intracranial Hemorrhages | 5 | 2019 | 844 | 0.340 |
Why?
|
| Sex Characteristics | 2 | 2018 | 2629 | 0.340 |
Why?
|
| DNA-Binding Proteins | 11 | 2024 | 9585 | 0.340 |
Why?
|
| Vasculitis | 4 | 2007 | 523 | 0.340 |
Why?
|
| Brain Abscess | 1 | 2010 | 120 | 0.330 |
Why?
|
| Social Adjustment | 1 | 2011 | 632 | 0.330 |
Why?
|
| Astrocytes | 11 | 2023 | 1338 | 0.330 |
Why?
|
| Gliosis | 6 | 2011 | 244 | 0.320 |
Why?
|
| Gyrus Cinguli | 2 | 2017 | 1114 | 0.320 |
Why?
|
| Affective Symptoms | 1 | 2011 | 416 | 0.320 |
Why?
|
| Spinal Cord | 8 | 2023 | 1817 | 0.310 |
Why?
|
| Apolipoprotein E4 | 7 | 2020 | 707 | 0.310 |
Why?
|
| Apolipoprotein E2 | 3 | 2020 | 135 | 0.310 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2021 | 1463 | 0.310 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 167 | 0.310 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2024 | 104 | 0.310 |
Why?
|
| CADASIL | 1 | 2009 | 88 | 0.310 |
Why?
|
| Sialic Acids | 7 | 2001 | 122 | 0.310 |
Why?
|
| Glioblastoma | 7 | 2024 | 3484 | 0.310 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2010 | 141 | 0.300 |
Why?
|
| Lewy Bodies | 4 | 2024 | 144 | 0.300 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 2007 | 26 | 0.300 |
Why?
|
| Positron-Emission Tomography | 16 | 2024 | 6465 | 0.300 |
Why?
|
| Phosphorylation | 13 | 2024 | 8313 | 0.300 |
Why?
|
| Staining and Labeling | 6 | 2020 | 1089 | 0.290 |
Why?
|
| Encephalitis | 4 | 2021 | 437 | 0.290 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 2008 | 133 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2017 | 1652 | 0.280 |
Why?
|
| Skin Diseases, Papulosquamous | 1 | 2006 | 17 | 0.280 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 397 | 0.280 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2015 | 266 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 13 | 2022 | 4407 | 0.270 |
Why?
|
| Antibodies | 3 | 2018 | 2421 | 0.270 |
Why?
|
| Metagenomics | 2 | 2021 | 457 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 11 | 2018 | 9185 | 0.260 |
Why?
|
| PrPSc Proteins | 1 | 2005 | 32 | 0.260 |
Why?
|
| Neuronal Plasticity | 4 | 2021 | 1430 | 0.260 |
Why?
|
| Oligodendroglioma | 2 | 2018 | 279 | 0.260 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 955 | 0.260 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 617 | 0.250 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 1403 | 0.250 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1504 | 0.250 |
Why?
|
| Aniline Compounds | 6 | 2019 | 1069 | 0.250 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 3 | 2011 | 41 | 0.250 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2023 | 38 | 0.240 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2005 | 91 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2023 | 8950 | 0.240 |
Why?
|
| Cerebellar Ataxia | 2 | 2024 | 149 | 0.240 |
Why?
|
| Ascites | 1 | 2006 | 338 | 0.240 |
Why?
|
| Dura Mater | 1 | 2006 | 290 | 0.240 |
Why?
|
| Brain Chemistry | 7 | 2017 | 959 | 0.240 |
Why?
|
| Immunization, Passive | 1 | 2007 | 616 | 0.240 |
Why?
|
| Meningioma | 5 | 2022 | 1221 | 0.240 |
Why?
|
| Movement Disorders | 2 | 2007 | 459 | 0.230 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 1 | 2024 | 10 | 0.230 |
Why?
|
| Atrophy | 5 | 2022 | 1627 | 0.230 |
Why?
|
| Dominance, Ocular | 2 | 2021 | 30 | 0.220 |
Why?
|
| Antigens, Helminth | 2 | 2000 | 68 | 0.220 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 21 | 0.220 |
Why?
|
| Molecular Imaging | 2 | 2024 | 818 | 0.220 |
Why?
|
| Nervous System Diseases | 3 | 2016 | 1647 | 0.220 |
Why?
|
| Chromatography, Gel | 2 | 2021 | 645 | 0.220 |
Why?
|
| Formates | 2 | 2021 | 40 | 0.220 |
Why?
|
| Blood-Brain Barrier | 4 | 2019 | 1019 | 0.220 |
Why?
|
| Lysosomal Storage Diseases | 3 | 2014 | 79 | 0.220 |
Why?
|
| Genes, Bacterial | 7 | 2001 | 1071 | 0.220 |
Why?
|
| Cerebrovascular Disorders | 5 | 2016 | 1501 | 0.210 |
Why?
|
| Disease Models, Animal | 26 | 2022 | 18137 | 0.210 |
Why?
|
| Striatonigral Degeneration | 1 | 2022 | 13 | 0.210 |
Why?
|
| Eosinophilia | 1 | 2007 | 559 | 0.210 |
Why?
|
| Microcirculation | 3 | 2015 | 1278 | 0.210 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 2022 | 19 | 0.210 |
Why?
|
| Immunohistochemistry | 24 | 2022 | 11071 | 0.210 |
Why?
|
| Sialyltransferases | 3 | 1997 | 81 | 0.210 |
Why?
|
| Consensus | 3 | 2019 | 3113 | 0.210 |
Why?
|
| Visual Cortex | 5 | 2021 | 1089 | 0.210 |
Why?
|
| Antigens, Surface | 4 | 2017 | 1608 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2024 | 4048 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 18 | 2017 | 3804 | 0.210 |
Why?
|
| Ascomycota | 1 | 2003 | 81 | 0.210 |
Why?
|
| S100 Proteins | 2 | 2000 | 218 | 0.210 |
Why?
|
| Membrane Proteins | 12 | 2014 | 7850 | 0.210 |
Why?
|
| Paresthesia | 2 | 2016 | 162 | 0.210 |
Why?
|
| RNA, Messenger | 11 | 2015 | 12766 | 0.200 |
Why?
|
| Phagocytes | 2 | 2003 | 296 | 0.200 |
Why?
|
| Dysarthria | 1 | 2022 | 58 | 0.200 |
Why?
|
| Temporal Arteries | 1 | 2003 | 148 | 0.200 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2022 | 74 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2020 | 17790 | 0.200 |
Why?
|
| Methylene Blue | 2 | 2012 | 157 | 0.200 |
Why?
|
| Adult | 56 | 2024 | 219994 | 0.200 |
Why?
|
| Vision, Ocular | 2 | 2017 | 454 | 0.200 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 469 | 0.190 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2021 | 33 | 0.190 |
Why?
|
| Meningeal Neoplasms | 3 | 2022 | 1249 | 0.190 |
Why?
|
| Fluorine Radioisotopes | 3 | 2019 | 413 | 0.190 |
Why?
|
| Cells, Cultured | 21 | 2021 | 18957 | 0.190 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2021 | 40 | 0.190 |
Why?
|
| Disease Progression | 15 | 2024 | 13502 | 0.190 |
Why?
|
| Telomerase | 2 | 2024 | 746 | 0.190 |
Why?
|
| Protein Multimerization | 4 | 2019 | 983 | 0.190 |
Why?
|
| Alternative Splicing | 3 | 2007 | 1091 | 0.190 |
Why?
|
| Dendrites | 3 | 2021 | 475 | 0.190 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 84 | 0.180 |
Why?
|
| Cerebral Veins | 1 | 2002 | 157 | 0.180 |
Why?
|
| Biopsy | 10 | 2016 | 6771 | 0.180 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 941 | 0.180 |
Why?
|
| Immunosuppressive Agents | 5 | 2020 | 4166 | 0.180 |
Why?
|
| HEK293 Cells | 6 | 2021 | 4264 | 0.180 |
Why?
|
| Vision Disorders | 2 | 2019 | 1084 | 0.180 |
Why?
|
| Heat-Shock Proteins | 3 | 2006 | 795 | 0.180 |
Why?
|
| Meninges | 4 | 2020 | 197 | 0.180 |
Why?
|
| Basal Ganglia Diseases | 1 | 2021 | 144 | 0.180 |
Why?
|
| Epitopes | 6 | 2017 | 2503 | 0.180 |
Why?
|
| Thiazoles | 6 | 2019 | 1511 | 0.180 |
Why?
|
| Telepathology | 2 | 2012 | 77 | 0.180 |
Why?
|
| Biophysics | 1 | 2021 | 380 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 1067 | 0.180 |
Why?
|
| Genetic Variation | 8 | 2018 | 6551 | 0.180 |
Why?
|
| Myocardium | 2 | 2016 | 4700 | 0.180 |
Why?
|
| Antigens, Differentiation | 2 | 2000 | 911 | 0.170 |
Why?
|
| Superoxide Dismutase | 2 | 2014 | 594 | 0.170 |
Why?
|
| Myocarditis | 1 | 2007 | 766 | 0.170 |
Why?
|
| Serine C-Palmitoyltransferase | 3 | 2011 | 42 | 0.170 |
Why?
|
| Cerebrospinal Fluid | 3 | 2007 | 544 | 0.170 |
Why?
|
| Inclusion Bodies | 5 | 2017 | 281 | 0.170 |
Why?
|
| Aging | 13 | 2023 | 8651 | 0.170 |
Why?
|
| Microscopy | 4 | 2018 | 885 | 0.170 |
Why?
|
| Meningitis | 1 | 2021 | 218 | 0.170 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2019 | 916 | 0.170 |
Why?
|
| Phenotype | 13 | 2024 | 16546 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 23 | 2019 | 22023 | 0.170 |
Why?
|
| Chordoma | 1 | 2023 | 346 | 0.170 |
Why?
|
| Cell Size | 1 | 2021 | 624 | 0.170 |
Why?
|
| Extracellular Fluid | 3 | 2019 | 165 | 0.170 |
Why?
|
| Bacterial Capsules | 3 | 1999 | 242 | 0.170 |
Why?
|
| Muscle Weakness | 2 | 2015 | 413 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2023 | 563 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 2782 | 0.170 |
Why?
|
| Case-Control Studies | 17 | 2021 | 22053 | 0.170 |
Why?
|
| Limbic Encephalitis | 1 | 2019 | 36 | 0.170 |
Why?
|
| Hypermedia | 1 | 1999 | 20 | 0.170 |
Why?
|
| Siderosis | 1 | 2020 | 103 | 0.170 |
Why?
|
| Tomography, Optical Coherence | 3 | 2018 | 2884 | 0.170 |
Why?
|
| Lipopolysaccharides | 6 | 2001 | 2209 | 0.160 |
Why?
|
| Occipital Lobe | 2 | 2019 | 373 | 0.160 |
Why?
|
| Homozygote | 3 | 2020 | 1788 | 0.160 |
Why?
|
| Solubility | 6 | 2012 | 1088 | 0.160 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2005 | 397 | 0.160 |
Why?
|
| Giant Cell Arteritis | 1 | 2003 | 295 | 0.160 |
Why?
|
| Nissl Bodies | 1 | 2018 | 16 | 0.160 |
Why?
|
| Calgranulin A | 4 | 2004 | 80 | 0.160 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1174 | 0.160 |
Why?
|
| Severity of Illness Index | 10 | 2021 | 15840 | 0.160 |
Why?
|
| Genetic Loci | 3 | 2019 | 2618 | 0.160 |
Why?
|
| Myoclonus | 1 | 2019 | 107 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2015 | 632 | 0.160 |
Why?
|
| Calgranulin B | 4 | 2004 | 86 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 109 | 0.160 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 916 | 0.160 |
Why?
|
| Atlases as Topic | 2 | 2017 | 241 | 0.160 |
Why?
|
| Hydrogels | 2 | 2024 | 723 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2014 | 238 | 0.160 |
Why?
|
| National Institute on Aging (U.S.) | 3 | 2015 | 39 | 0.160 |
Why?
|
| Tuberous Sclerosis | 3 | 2009 | 1030 | 0.160 |
Why?
|
| Microbiology | 1 | 1999 | 73 | 0.160 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2018 | 42 | 0.150 |
Why?
|
| Genes, Helminth | 2 | 2000 | 146 | 0.150 |
Why?
|
| Mammals | 2 | 2021 | 1131 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2003 | 648 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 1992 | 1132 | 0.150 |
Why?
|
| Genotype | 15 | 2020 | 12960 | 0.150 |
Why?
|
| Peripheral Nerves | 2 | 2021 | 475 | 0.150 |
Why?
|
| Sterol O-Acyltransferase | 2 | 2010 | 28 | 0.150 |
Why?
|
| Amyloidosis | 3 | 2016 | 817 | 0.150 |
Why?
|
| Up-Regulation | 9 | 2019 | 4122 | 0.150 |
Why?
|
| Metagenome | 1 | 2021 | 450 | 0.150 |
Why?
|
| Genome-Wide Association Study | 9 | 2022 | 12626 | 0.150 |
Why?
|
| Apolipoproteins E | 8 | 2014 | 1436 | 0.150 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2018 | 37 | 0.150 |
Why?
|
| Viruses | 1 | 2021 | 376 | 0.150 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 43 | 0.150 |
Why?
|
| Mycoplasma hominis | 1 | 1997 | 10 | 0.150 |
Why?
|
| Perceptual Disorders | 1 | 2019 | 197 | 0.140 |
Why?
|
| Chaperonin 60 | 1 | 1997 | 97 | 0.140 |
Why?
|
| Endothelium | 1 | 2000 | 764 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 130 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 2 | 2019 | 901 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 537 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 4 | 2017 | 1343 | 0.140 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 415 | 0.140 |
Why?
|
| Radiography | 7 | 2016 | 6965 | 0.140 |
Why?
|
| Membrane Glycoproteins | 4 | 2017 | 3707 | 0.140 |
Why?
|
| Pathology, Clinical | 2 | 2012 | 375 | 0.140 |
Why?
|
| Gene Expression | 6 | 2017 | 7588 | 0.140 |
Why?
|
| Pseudomonas aeruginosa | 2 | 1997 | 1276 | 0.140 |
Why?
|
| Enterobacteriaceae | 1 | 2018 | 172 | 0.140 |
Why?
|
| Mycoplasma Infections | 1 | 1997 | 120 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 2005 | 752 | 0.140 |
Why?
|
| Species Specificity | 6 | 2021 | 2418 | 0.140 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 219 | 0.140 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 1881 | 0.140 |
Why?
|
| Single-Cell Analysis | 5 | 2021 | 2380 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 6 | 2018 | 4713 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2021 | 707 | 0.140 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 15 | 0.140 |
Why?
|
| Olfactory Pathways | 1 | 2017 | 132 | 0.140 |
Why?
|
| Neostriatum | 1 | 2017 | 246 | 0.130 |
Why?
|
| Gene Dosage | 5 | 2019 | 1218 | 0.130 |
Why?
|
| Heterozygote | 5 | 2016 | 2798 | 0.130 |
Why?
|
| Pyridines | 3 | 2024 | 2879 | 0.130 |
Why?
|
| Reagent Strips | 1 | 1996 | 39 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 192 | 0.130 |
Why?
|
| Stroke | 7 | 2013 | 9962 | 0.130 |
Why?
|
| beta-Lactamases | 1 | 2018 | 304 | 0.130 |
Why?
|
| Nerve Degeneration | 2 | 2012 | 748 | 0.130 |
Why?
|
| Paraplegia | 1 | 2016 | 162 | 0.130 |
Why?
|
| Erythrocyte Count | 1 | 1996 | 157 | 0.130 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2005 | 1079 | 0.130 |
Why?
|
| MELAS Syndrome | 1 | 2016 | 56 | 0.130 |
Why?
|
| Amyloidogenic Proteins | 1 | 2016 | 151 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2000 | 915 | 0.130 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 173 | 0.130 |
Why?
|
| Molecular Sequence Data | 14 | 2002 | 17624 | 0.130 |
Why?
|
| Escherichia coli O157 | 4 | 1999 | 53 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.130 |
Why?
|
| Oncogenes | 2 | 2018 | 1220 | 0.130 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2019 | 952 | 0.130 |
Why?
|
| Tissue Donors | 2 | 2024 | 2313 | 0.130 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2016 | 85 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2023 | 1252 | 0.130 |
Why?
|
| Blood Vessels | 3 | 2024 | 1112 | 0.130 |
Why?
|
| Age of Onset | 7 | 2020 | 3301 | 0.130 |
Why?
|
| Immunoblotting | 7 | 2016 | 1649 | 0.130 |
Why?
|
| Receptors, Notch | 2 | 2011 | 743 | 0.130 |
Why?
|
| Point Mutation | 3 | 2016 | 1594 | 0.120 |
Why?
|
| Serotyping | 5 | 2000 | 324 | 0.120 |
Why?
|
| Smell | 1 | 2017 | 259 | 0.120 |
Why?
|
| Ubiquitin | 2 | 2012 | 838 | 0.120 |
Why?
|
| Cell Survival | 3 | 2021 | 5797 | 0.120 |
Why?
|
| Tissue Preservation | 1 | 2015 | 174 | 0.120 |
Why?
|
| Aspergillosis | 3 | 2002 | 243 | 0.120 |
Why?
|
| N-Acylneuraminate Cytidylyltransferase | 1 | 1994 | 6 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 152 | 0.120 |
Why?
|
| Vasoconstriction | 2 | 2016 | 593 | 0.120 |
Why?
|
| Choroid Plexus | 1 | 2018 | 237 | 0.120 |
Why?
|
| Knowledge | 1 | 2016 | 176 | 0.120 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2016 | 124 | 0.120 |
Why?
|
| Visual Pathways | 2 | 2017 | 534 | 0.120 |
Why?
|
| Exons | 4 | 2022 | 2388 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2005 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2013 | 3340 | 0.120 |
Why?
|
| G(M2) Ganglioside | 1 | 2014 | 15 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2021 | 15789 | 0.120 |
Why?
|
| Hemosiderosis | 1 | 2015 | 66 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 581 | 0.120 |
Why?
|
| Huntington Disease | 2 | 2012 | 1141 | 0.120 |
Why?
|
| Carrier State | 1 | 2018 | 525 | 0.120 |
Why?
|
| Ion Channels | 3 | 2018 | 1043 | 0.120 |
Why?
|
| Brain Infarction | 1 | 2016 | 292 | 0.120 |
Why?
|
| Base Sequence | 10 | 2002 | 12446 | 0.120 |
Why?
|
| Caspases | 2 | 2008 | 878 | 0.120 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2014 | 27 | 0.120 |
Why?
|
| Family Health | 2 | 2017 | 1257 | 0.120 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1411 | 0.120 |
Why?
|
| Shoes | 1 | 2014 | 94 | 0.120 |
Why?
|
| Tomography, Emission-Computed | 4 | 2002 | 1121 | 0.120 |
Why?
|
| Lipoproteins | 2 | 2001 | 882 | 0.110 |
Why?
|
| Oligodendroglia | 1 | 2018 | 536 | 0.110 |
Why?
|
| Proteomics | 3 | 2023 | 3817 | 0.110 |
Why?
|
| Arterioles | 3 | 2011 | 250 | 0.110 |
Why?
|
| Meningitis, Bacterial | 1 | 1996 | 221 | 0.110 |
Why?
|
| Essential Tremor | 1 | 2016 | 157 | 0.110 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 1972 | 0.110 |
Why?
|
| Crystallins | 1 | 1993 | 75 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2022 | 1056 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 2895 | 0.110 |
Why?
|
| Racemases and Epimerases | 1 | 1994 | 112 | 0.110 |
Why?
|
| Multigene Family | 2 | 2011 | 1077 | 0.110 |
Why?
|
| Antigenic Variation | 1 | 1994 | 118 | 0.110 |
Why?
|
| Oxidative Stress | 4 | 2012 | 3106 | 0.110 |
Why?
|
| Rats | 18 | 2018 | 23711 | 0.110 |
Why?
|
| Plasmapheresis | 1 | 2014 | 206 | 0.110 |
Why?
|
| Image Enhancement | 3 | 2013 | 2881 | 0.110 |
Why?
|
| Cohort Studies | 15 | 2021 | 41335 | 0.110 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1994 | 574 | 0.110 |
Why?
|
| Axons | 3 | 2019 | 1673 | 0.110 |
Why?
|
| Hallucinations | 1 | 2016 | 366 | 0.110 |
Why?
|
| Gene Expression Regulation | 8 | 2018 | 11903 | 0.110 |
Why?
|
| Hematologic Tests | 1 | 2014 | 238 | 0.110 |
Why?
|
| Neocortex | 4 | 2017 | 416 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 1485 | 0.110 |
Why?
|
| Protein Isoforms | 6 | 2018 | 1697 | 0.110 |
Why?
|
| Genetic Association Studies | 3 | 2024 | 2717 | 0.110 |
Why?
|
| Eye | 1 | 2017 | 710 | 0.110 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2020 | 550 | 0.110 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 351 | 0.110 |
Why?
|
| Immunity | 1 | 2019 | 998 | 0.110 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.110 |
Why?
|
| Supranuclear Palsy, Progressive | 2 | 2017 | 80 | 0.100 |
Why?
|
| Cell Line | 8 | 2020 | 15620 | 0.100 |
Why?
|
| Amino Acid Sequence | 10 | 2017 | 13451 | 0.100 |
Why?
|
| Quantitative Trait Loci | 2 | 2018 | 2101 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2016 | 1744 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1255 | 0.100 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2013 | 34 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 1299 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 635 | 0.100 |
Why?
|
| Peptides | 3 | 2023 | 4354 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2016 | 342 | 0.100 |
Why?
|
| Neurites | 2 | 2015 | 390 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2014 | 247 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 3 | 2012 | 428 | 0.100 |
Why?
|
| Amnesia | 1 | 2014 | 255 | 0.100 |
Why?
|
| Blotting, Western | 8 | 2017 | 5039 | 0.100 |
Why?
|
| Cytokines | 2 | 2018 | 7343 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2414 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 4902 | 0.100 |
Why?
|
| Amyloid Precursor Protein Secretases | 4 | 2010 | 620 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 115 | 0.100 |
Why?
|
| Sensory Deprivation | 1 | 2012 | 106 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 496 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1347 | 0.100 |
Why?
|
| Prefrontal Cortex | 2 | 2022 | 2212 | 0.100 |
Why?
|
| Retrospective Studies | 20 | 2024 | 80372 | 0.100 |
Why?
|
| Sphingolipids | 2 | 2011 | 173 | 0.100 |
Why?
|
| CHO Cells | 7 | 2018 | 1389 | 0.100 |
Why?
|
| Melanoma | 2 | 2022 | 5697 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2020 | 3790 | 0.100 |
Why?
|
| Coloring Agents | 2 | 2012 | 562 | 0.100 |
Why?
|
| Diagnostic Imaging | 4 | 2012 | 3527 | 0.100 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Neural Pathways | 2 | 2021 | 3040 | 0.100 |
Why?
|
| Melanins | 2 | 2024 | 291 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2802 | 0.090 |
Why?
|
| Wechsler Scales | 1 | 2011 | 257 | 0.090 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 3844 | 0.090 |
Why?
|
| Sick Role | 1 | 2011 | 230 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2011 | 282 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 9 | 2012 | 6068 | 0.090 |
Why?
|
| Neuroglia | 3 | 2023 | 944 | 0.090 |
Why?
|
| Insulysin | 3 | 2011 | 49 | 0.090 |
Why?
|
| Walking | 2 | 2016 | 1189 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 1527 | 0.090 |
Why?
|
| Apolipoprotein E3 | 3 | 2020 | 107 | 0.090 |
Why?
|
| Back Pain | 1 | 2015 | 543 | 0.090 |
Why?
|
| Cricetulus | 5 | 2018 | 815 | 0.090 |
Why?
|
| Tomography | 1 | 2013 | 411 | 0.090 |
Why?
|
| Lung Diseases, Fungal | 2 | 2002 | 126 | 0.090 |
Why?
|
| Detergents | 4 | 2006 | 235 | 0.090 |
Why?
|
| Neurotoxins | 1 | 2011 | 240 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 1796 | 0.090 |
Why?
|
| Cricetinae | 8 | 2010 | 2427 | 0.090 |
Why?
|
| Haplotypes | 4 | 2024 | 2764 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2013 | 510 | 0.090 |
Why?
|
| Alkenes | 3 | 2009 | 54 | 0.090 |
Why?
|
| Streptococcus anginosus | 1 | 2010 | 24 | 0.090 |
Why?
|
| Rats, Wistar | 4 | 2018 | 1850 | 0.090 |
Why?
|
| Cerebral Angiography | 1 | 2016 | 1274 | 0.090 |
Why?
|
| Ligases | 2 | 2002 | 332 | 0.090 |
Why?
|
| Receptors, GABA | 2 | 2022 | 305 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 1997 | 4169 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2012 | 2362 | 0.090 |
Why?
|
| Sulfonic Acids | 1 | 2010 | 102 | 0.090 |
Why?
|
| Microfilament Proteins | 3 | 2015 | 1135 | 0.090 |
Why?
|
| Bacterial Toxins | 4 | 1999 | 931 | 0.090 |
Why?
|
| Alleles | 4 | 2020 | 6898 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 979 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 961 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2020 | 1870 | 0.090 |
Why?
|
| Phagocytosis | 5 | 2017 | 1535 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 7593 | 0.090 |
Why?
|
| Combined Modality Therapy | 6 | 2016 | 8552 | 0.090 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20080 | 0.090 |
Why?
|
| Algorithms | 5 | 2019 | 13981 | 0.090 |
Why?
|
| Hyperoxaluria | 1 | 1989 | 32 | 0.090 |
Why?
|
| Hyperoxaluria, Primary | 1 | 1989 | 24 | 0.090 |
Why?
|
| Lipids | 2 | 2019 | 3336 | 0.090 |
Why?
|
| Personality Assessment | 1 | 2011 | 650 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2017 | 2440 | 0.080 |
Why?
|
| Sphingosine | 1 | 2011 | 308 | 0.080 |
Why?
|
| Purines | 1 | 2013 | 605 | 0.080 |
Why?
|
| Endopeptidases | 2 | 2004 | 772 | 0.080 |
Why?
|
| Epistaxis | 1 | 2010 | 111 | 0.080 |
Why?
|
| Diseases in Twins | 2 | 2002 | 447 | 0.080 |
Why?
|
| Transaminases | 1 | 2010 | 196 | 0.080 |
Why?
|
| Societies, Medical | 2 | 2012 | 3905 | 0.080 |
Why?
|
| Down Syndrome | 1 | 2017 | 892 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2016 | 2985 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.080 |
Why?
|
| Amygdala | 1 | 2017 | 1351 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2011 | 626 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1992 | 407 | 0.080 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2009 | 45 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3616 | 0.080 |
Why?
|
| Proteins | 2 | 2014 | 6029 | 0.080 |
Why?
|
| Acetates | 1 | 2010 | 321 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2044 | 0.080 |
Why?
|
| Age Factors | 8 | 2016 | 18416 | 0.080 |
Why?
|
| Contractile Proteins | 1 | 2010 | 240 | 0.080 |
Why?
|
| Fusobacterium nucleatum | 1 | 2010 | 165 | 0.080 |
Why?
|
| Blood Bactericidal Activity | 2 | 1999 | 126 | 0.080 |
Why?
|
| Postmortem Changes | 4 | 2013 | 119 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 5508 | 0.080 |
Why?
|
| Water | 1 | 2015 | 1407 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2018 | 8158 | 0.080 |
Why?
|
| Molecular Weight | 3 | 2018 | 2186 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 1992 | 362 | 0.080 |
Why?
|
| Stereotaxic Techniques | 2 | 2010 | 549 | 0.080 |
Why?
|
| Blindness | 2 | 2017 | 582 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2014 | 1440 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 2 | 2010 | 2733 | 0.080 |
Why?
|
| Dissection | 2 | 2024 | 298 | 0.080 |
Why?
|
| Cervical Vertebrae | 2 | 2015 | 978 | 0.080 |
Why?
|
| Neurosurgical Procedures | 3 | 2024 | 2056 | 0.080 |
Why?
|
| Calcinosis | 1 | 2017 | 1476 | 0.080 |
Why?
|
| Child | 17 | 2023 | 79806 | 0.080 |
Why?
|
| Dermatomyositis | 1 | 2011 | 256 | 0.080 |
Why?
|
| DNA Repeat Expansion | 2 | 2021 | 72 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2017 | 3682 | 0.070 |
Why?
|
| Adolescent | 18 | 2019 | 87810 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2004 | 4938 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 1313 | 0.070 |
Why?
|
| Serine | 1 | 2011 | 830 | 0.070 |
Why?
|
| Ataxia | 1 | 2010 | 305 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2015 | 7475 | 0.070 |
Why?
|
| Cerebral Arteries | 4 | 2010 | 493 | 0.070 |
Why?
|
| Meningitis, Meningococcal | 2 | 1998 | 44 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2009 | 416 | 0.070 |
Why?
|
| Migraine with Aura | 1 | 2010 | 203 | 0.070 |
Why?
|
| Ultrasonography | 4 | 2012 | 5961 | 0.070 |
Why?
|
| Threonine | 1 | 2008 | 272 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2011 | 662 | 0.070 |
Why?
|
| Antigens, CD | 3 | 2011 | 4000 | 0.070 |
Why?
|
| Drainage | 1 | 2013 | 1161 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 448 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 2015 | 4433 | 0.070 |
Why?
|
| Antifungal Agents | 2 | 2003 | 749 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2017 | 2753 | 0.070 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2015 | 556 | 0.070 |
Why?
|
| Gene Frequency | 5 | 2017 | 3615 | 0.070 |
Why?
|
| Aphasia | 1 | 2009 | 192 | 0.070 |
Why?
|
| Ischemia | 2 | 2013 | 1893 | 0.070 |
Why?
|
| Subdural Effusion | 1 | 2006 | 19 | 0.070 |
Why?
|
| Child, Preschool | 12 | 2019 | 42063 | 0.070 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 214 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 234 | 0.070 |
Why?
|
| Long-Term Potentiation | 2 | 2019 | 293 | 0.070 |
Why?
|
| Workflow | 2 | 2022 | 852 | 0.070 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 15289 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3600 | 0.070 |
Why?
|
| Dipeptides | 1 | 2009 | 409 | 0.070 |
Why?
|
| Electric Conductivity | 2 | 2021 | 410 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2015 | 1194 | 0.070 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2006 | 107 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2011 | 805 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 865 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2011 | 1134 | 0.070 |
Why?
|
| Nephritis | 1 | 1987 | 149 | 0.070 |
Why?
|
| Uric Acid | 1 | 2013 | 806 | 0.070 |
Why?
|
| DNA Primers | 5 | 2002 | 2819 | 0.070 |
Why?
|
| Prealbumin | 1 | 2008 | 222 | 0.070 |
Why?
|
| Least-Squares Analysis | 2 | 2018 | 369 | 0.070 |
Why?
|
| Proline | 1 | 2008 | 457 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2007 | 397 | 0.070 |
Why?
|
| Embolism | 1 | 2010 | 408 | 0.070 |
Why?
|
| Protein Binding | 5 | 2019 | 9335 | 0.070 |
Why?
|
| Genetic Heterogeneity | 2 | 2020 | 724 | 0.070 |
Why?
|
| Chromatography, Liquid | 2 | 2023 | 987 | 0.070 |
Why?
|
| Plasmids | 4 | 1999 | 2275 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2009 | 943 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 994 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2009 | 552 | 0.070 |
Why?
|
| Cortical Spreading Depression | 1 | 2010 | 288 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 796 | 0.070 |
Why?
|
| Electron Transport Complex IV | 1 | 2006 | 190 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 568 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 2651 | 0.070 |
Why?
|
| Escherichia coli | 4 | 2017 | 4219 | 0.070 |
Why?
|
| Epilepsy | 3 | 2014 | 3267 | 0.070 |
Why?
|
| Sensitivity and Specificity | 8 | 2019 | 14660 | 0.070 |
Why?
|
| PrPC Proteins | 1 | 2005 | 37 | 0.060 |
Why?
|
| Electroencephalography | 4 | 2010 | 6189 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2005 | 81 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2016 | 9276 | 0.060 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 9411 | 0.060 |
Why?
|
| Prospective Studies | 10 | 2024 | 54303 | 0.060 |
Why?
|
| Blood Proteins | 3 | 2019 | 1173 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 247 | 0.060 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 437 | 0.060 |
Why?
|
| Isoflurane | 1 | 2008 | 384 | 0.060 |
Why?
|
| Papilledema | 1 | 2006 | 130 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2018 | 6796 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 755 | 0.060 |
Why?
|
| Reperfusion Injury | 2 | 2005 | 1023 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 1988 | 523 | 0.060 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 340 | 0.060 |
Why?
|
| Measles | 1 | 2007 | 185 | 0.060 |
Why?
|
| Linkage Disequilibrium | 3 | 2017 | 1996 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2010 | 2913 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2007 | 350 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 1997 | 2325 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3047 | 0.060 |
Why?
|
| Steroids | 1 | 2010 | 928 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8056 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2024 | 5785 | 0.060 |
Why?
|
| Capillaries | 3 | 2019 | 744 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 1985 | 461 | 0.060 |
Why?
|
| Inflammation | 5 | 2020 | 10756 | 0.060 |
Why?
|
| Young Adult | 12 | 2020 | 58741 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2019 | 1967 | 0.060 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 409 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 67 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 1952 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 2006 | 2672 | 0.060 |
Why?
|
| Genetic Testing | 3 | 2019 | 3531 | 0.060 |
Why?
|
| Liver | 4 | 2010 | 7509 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 2 | 2004 | 2471 | 0.060 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 3726 | 0.060 |
Why?
|
| Brain Mapping | 5 | 2023 | 6568 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2004 | 64 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 745 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2009 | 749 | 0.060 |
Why?
|
| Quinazolines | 1 | 2011 | 1363 | 0.060 |
Why?
|
| DNA Mutational Analysis | 6 | 2011 | 4107 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 1985 | 406 | 0.060 |
Why?
|
| Porins | 2 | 2001 | 79 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 333 | 0.060 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2002 | 173 | 0.060 |
Why?
|
| HIV | 1 | 2011 | 1579 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6015 | 0.060 |
Why?
|
| Paecilomyces | 1 | 2003 | 3 | 0.060 |
Why?
|
| Recurrence | 5 | 2020 | 8482 | 0.060 |
Why?
|
| Protein Folding | 3 | 2014 | 867 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 1992 | 1462 | 0.060 |
Why?
|
| Lysophosphatidylcholines | 2 | 2017 | 77 | 0.060 |
Why?
|
| Lasers | 1 | 1988 | 952 | 0.060 |
Why?
|
| Recombinant Proteins | 6 | 2017 | 6538 | 0.060 |
Why?
|
| Cholinergic Agents | 1 | 2023 | 96 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2010 | 1233 | 0.060 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2003 | 27 | 0.060 |
Why?
|
| Receptors, Cell Surface | 4 | 2021 | 2825 | 0.060 |
Why?
|
| Lipid Bilayers | 1 | 1985 | 383 | 0.060 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 574 | 0.060 |
Why?
|
| Monoamine Oxidase | 1 | 2024 | 178 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10181 | 0.050 |
Why?
|
| Confusion | 1 | 2005 | 279 | 0.050 |
Why?
|
| Notochord | 1 | 2023 | 37 | 0.050 |
Why?
|
| Escherichia coli Infections | 4 | 1999 | 523 | 0.050 |
Why?
|
| Dermatomycoses | 1 | 2003 | 48 | 0.050 |
Why?
|
| Databases, Factual | 1 | 1999 | 8035 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 697 | 0.050 |
Why?
|
| Pyrimidinones | 1 | 1985 | 384 | 0.050 |
Why?
|
| Mesencephalon | 2 | 2003 | 332 | 0.050 |
Why?
|
| Mice, Knockout | 7 | 2017 | 14372 | 0.050 |
Why?
|
| Dementia, Multi-Infarct | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mice, Inbred C3H | 2 | 2017 | 915 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 423 | 0.050 |
Why?
|
| Exanthema | 1 | 2007 | 504 | 0.050 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 39261 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 863 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2011 | 2838 | 0.050 |
Why?
|
| Mass Spectrometry | 3 | 2016 | 2192 | 0.050 |
Why?
|
| Congo Red | 1 | 2002 | 48 | 0.050 |
Why?
|
| Olfactory Bulb | 1 | 1984 | 198 | 0.050 |
Why?
|
| Advance Directives | 1 | 2004 | 248 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 2016 | 1229 | 0.050 |
Why?
|
| Monocytes | 2 | 2014 | 2575 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2262 | 0.050 |
Why?
|
| Immunoglobulin G | 5 | 2019 | 4541 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 1405 | 0.050 |
Why?
|
| Brain Diseases | 2 | 2009 | 1540 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2003 | 185 | 0.050 |
Why?
|
| Benzene Derivatives | 3 | 2009 | 53 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2003 | 270 | 0.050 |
Why?
|
| DNA, Bacterial | 3 | 2000 | 1456 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2002 | 1889 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2022 | 123 | 0.050 |
Why?
|
| Benzene | 1 | 2002 | 106 | 0.050 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 1999 | 106 | 0.050 |
Why?
|
| Infant | 7 | 2019 | 36060 | 0.050 |
Why?
|
| Open Reading Frames | 3 | 1998 | 814 | 0.050 |
Why?
|
| Chelating Agents | 2 | 2002 | 384 | 0.050 |
Why?
|
| Spinal Cord Diseases | 1 | 2005 | 293 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4573 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2005 | 625 | 0.050 |
Why?
|
| DNA, Fungal | 1 | 2003 | 275 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2471 | 0.050 |
Why?
|
| Seizures | 3 | 2010 | 2917 | 0.050 |
Why?
|
| Germany | 4 | 2011 | 873 | 0.050 |
Why?
|
| Fatty Acids | 2 | 2015 | 1804 | 0.050 |
Why?
|
| Hypotension | 1 | 2007 | 883 | 0.050 |
Why?
|
| Anticoagulants | 2 | 2019 | 4897 | 0.050 |
Why?
|
| Antigens, Human Platelet | 1 | 2001 | 41 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 1959 | 0.050 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2003 | 165 | 0.050 |
Why?
|
| Antibodies, Fungal | 1 | 2001 | 34 | 0.050 |
Why?
|
| Oculomotor Nerve | 1 | 2001 | 72 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2006 | 5649 | 0.050 |
Why?
|
| Tritium | 2 | 2017 | 707 | 0.050 |
Why?
|
| Trematoda | 1 | 2000 | 3 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 2005 | 412 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 2001 | 410 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2006 | 619 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1999 | 852 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1921 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2023 | 226 | 0.050 |
Why?
|
| Legionella pneumophila | 1 | 2001 | 49 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2016 | 6360 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 3484 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2001 | 130 | 0.050 |
Why?
|
| Stilbenes | 3 | 2009 | 155 | 0.050 |
Why?
|
| Photography | 1 | 2024 | 530 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2007 | 2007 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 1995 | 263 | 0.050 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2021 | 141 | 0.050 |
Why?
|
| RNA, Helminth | 1 | 2000 | 60 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3426 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2022 | 2118 | 0.050 |
Why?
|
| Meningococcal Vaccines | 1 | 2001 | 94 | 0.050 |
Why?
|
| Status Epilepticus | 1 | 2006 | 456 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1898 | 0.050 |
Why?
|
| Prognosis | 5 | 2024 | 29658 | 0.050 |
Why?
|
| Candida | 1 | 2001 | 173 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 623 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 2049 | 0.050 |
Why?
|
| Neisseriaceae | 1 | 2000 | 6 | 0.050 |
Why?
|
| Methanol | 1 | 2001 | 91 | 0.040 |
Why?
|
| Transfection | 5 | 2012 | 5781 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2001 | 198 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2001 | 277 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2019 | 9716 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2011 | 1738 | 0.040 |
Why?
|
| Diarrhea | 4 | 1999 | 1319 | 0.040 |
Why?
|
| Nerve Net | 1 | 2012 | 2261 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2023 | 468 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2016 | 20509 | 0.040 |
Why?
|
| Dilatation | 1 | 2021 | 307 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2010 | 5434 | 0.040 |
Why?
|
| Thapsigargin | 1 | 2000 | 102 | 0.040 |
Why?
|
| Cell Count | 3 | 2013 | 1835 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2006 | 1063 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2000 | 113 | 0.040 |
Why?
|
| Acrylamide | 1 | 2020 | 59 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 2000 | 169 | 0.040 |
Why?
|
| Foxes | 1 | 1999 | 10 | 0.040 |
Why?
|
| Mitochondria | 2 | 2011 | 3600 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1528 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2004 | 495 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 1459 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2002 | 469 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2020 | 102 | 0.040 |
Why?
|
| Fever | 1 | 2007 | 1617 | 0.040 |
Why?
|
| Echinococcosis, Hepatic | 1 | 1999 | 24 | 0.040 |
Why?
|
| Cadaver | 2 | 2015 | 1345 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 2001 | 156 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2017 | 806 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 295 | 0.040 |
Why?
|
| Putamen | 1 | 2001 | 291 | 0.040 |
Why?
|
| Risk Factors | 9 | 2019 | 74359 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 2020 | 83 | 0.040 |
Why?
|
| Mycoses | 1 | 2003 | 387 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 542 | 0.040 |
Why?
|
| Eye Enucleation | 2 | 2012 | 128 | 0.040 |
Why?
|
| Constipation | 1 | 2004 | 561 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2001 | 370 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2020 | 316 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 2013 | 0.040 |
Why?
|
| Trinucleotide Repeats | 2 | 2013 | 257 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 4625 | 0.040 |
Why?
|
| Nucleotides | 1 | 2022 | 450 | 0.040 |
Why?
|
| Time Factors | 8 | 2021 | 40165 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2001 | 392 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 1987 | 1403 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2020 | 210 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14495 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 2010 | 297 | 0.040 |
Why?
|
| Tensile Strength | 1 | 2020 | 330 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 608 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12159 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 10827 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2019 | 2533 | 0.040 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 25942 | 0.040 |
Why?
|
| Vasomotor System | 1 | 2019 | 207 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2024 | 820 | 0.040 |
Why?
|
| Gait | 1 | 2004 | 812 | 0.040 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 1 | 1998 | 18 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11712 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2015 | 1126 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4899 | 0.040 |
Why?
|
| Receptors, LHRH | 1 | 1999 | 158 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2018 | 44 | 0.040 |
Why?
|
| Genes, myc | 1 | 2020 | 395 | 0.040 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 1303 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 2019 | 149 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2018 | 225 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1997 | 1060 | 0.040 |
Why?
|
| Biomimetic Materials | 1 | 2020 | 173 | 0.040 |
Why?
|
| Language Disorders | 1 | 2019 | 138 | 0.040 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2003 | 584 | 0.040 |
Why?
|
| Exudates and Transudates | 1 | 2019 | 175 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2001 | 1955 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2004 | 626 | 0.040 |
Why?
|
| Capillary Permeability | 2 | 2019 | 768 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2015 | 508 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 1097 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2013 | 23376 | 0.040 |
Why?
|
| Action Potentials | 4 | 2018 | 1816 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9467 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2018 | 100 | 0.040 |
Why?
|
| Collagenases | 1 | 1998 | 221 | 0.040 |
Why?
|
| Immunoglobulin A | 2 | 2001 | 979 | 0.040 |
Why?
|
| Efficiency | 1 | 2021 | 477 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 286 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2019 | 1167 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2021 | 370 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2011 | 3127 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 3 | 1988 | 806 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 1060 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 978 | 0.040 |
Why?
|
| Microscopy, Electron | 4 | 2008 | 2558 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 1999 | 285 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6238 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2282 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2001 | 661 | 0.040 |
Why?
|
| Memory Disorders | 2 | 2019 | 1197 | 0.040 |
Why?
|
| Vaccination | 1 | 2010 | 3361 | 0.040 |
Why?
|
| Glycolipids | 1 | 1998 | 204 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 587 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 1 | 2018 | 260 | 0.040 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 1902 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 965 | 0.040 |
Why?
|
| Apoptosis | 2 | 2008 | 9501 | 0.040 |
Why?
|
| Unilamellar Liposomes | 1 | 2017 | 11 | 0.040 |
Why?
|
| Angiomatosis | 1 | 1997 | 46 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1997 | 1628 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 691 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 685 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 819 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2017 | 163 | 0.040 |
Why?
|
| Integrins | 1 | 2001 | 839 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2001 | 911 | 0.030 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1999 | 238 | 0.030 |
Why?
|
| Liver Abscess | 1 | 1997 | 81 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 1674 | 0.030 |
Why?
|
| Antigens, Bacterial | 2 | 2001 | 1155 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2022 | 12103 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1189 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2000 | 619 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2017 | 366 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1997 | 333 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1999 | 524 | 0.030 |
Why?
|
| Materials Testing | 1 | 2020 | 862 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 2001 | 1529 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2021 | 1516 | 0.030 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1693 | 0.030 |
Why?
|
| Protein Transport | 2 | 2012 | 1964 | 0.030 |
Why?
|
| Reducing Agents | 1 | 2015 | 12 | 0.030 |
Why?
|
| Octoxynol | 2 | 2006 | 77 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1999 | 637 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2017 | 369 | 0.030 |
Why?
|
| Fibrin | 1 | 2019 | 505 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2000 | 756 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 1995 | 35 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 367 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10446 | 0.030 |
Why?
|
| Cost Savings | 1 | 2021 | 920 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 165 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2002 | 708 | 0.030 |
Why?
|
| Voluntary Health Agencies | 1 | 2015 | 38 | 0.030 |
Why?
|
| Gastritis | 1 | 1997 | 198 | 0.030 |
Why?
|
| Electrophysiology | 2 | 1992 | 1265 | 0.030 |
Why?
|
| Complement C3 | 1 | 1997 | 451 | 0.030 |
Why?
|
| Protein Conformation | 3 | 2005 | 3969 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 1998 | 344 | 0.030 |
Why?
|
| Shiga Toxins | 3 | 1999 | 40 | 0.030 |
Why?
|
| Kinetics | 4 | 2006 | 6377 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2000 | 587 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13262 | 0.030 |
Why?
|
| Pleura | 1 | 1997 | 244 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1997 | 818 | 0.030 |
Why?
|
| Neprilysin | 2 | 2011 | 472 | 0.030 |
Why?
|
| Anisotropy | 1 | 2019 | 1278 | 0.030 |
Why?
|
| Survival Rate | 3 | 2024 | 12808 | 0.030 |
Why?
|
| Mutation, Missense | 3 | 2011 | 2566 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 2 | 2009 | 265 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 709 | 0.030 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2014 | 14 | 0.030 |
Why?
|
| Aorta | 1 | 2003 | 2039 | 0.030 |
Why?
|
| Genomics | 2 | 2022 | 5794 | 0.030 |
Why?
|
| Medulloblastoma | 1 | 2000 | 679 | 0.030 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2014 | 44 | 0.030 |
Why?
|
| Synaptophysin | 2 | 2006 | 139 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1998 | 1055 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 268 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.030 |
Why?
|
| Bacterial Proteins | 3 | 2001 | 3826 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 1666 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2001 | 1343 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 8469 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 2803 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 2394 | 0.030 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 1994 | 7 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.030 |
Why?
|
| Neurology | 1 | 2002 | 779 | 0.030 |
Why?
|
| Probability | 1 | 2020 | 2475 | 0.030 |
Why?
|
| Sheep Diseases | 1 | 1994 | 18 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1996 | 1154 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 207 | 0.030 |
Why?
|
| Echinococcosis | 1 | 1994 | 31 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 1997 | 377 | 0.030 |
Why?
|
| Dermoscopy | 1 | 2014 | 66 | 0.030 |
Why?
|
| Melanocytes | 1 | 2018 | 512 | 0.030 |
Why?
|
| Egypt | 1 | 1994 | 98 | 0.030 |
Why?
|
| Helicobacter Infections | 1 | 1997 | 386 | 0.030 |
Why?
|
| Afghanistan | 1 | 1994 | 79 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 658 | 0.030 |
Why?
|
| Drosophila | 1 | 2021 | 1492 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 246 | 0.030 |
Why?
|
| Cocaine | 1 | 2019 | 961 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1995 | 1991 | 0.030 |
Why?
|
| Parkinsonian Disorders | 2 | 2011 | 284 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1999 | 1021 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 940 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1994 | 195 | 0.030 |
Why?
|
| Skull Base | 1 | 2016 | 291 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 1513 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2001 | 1055 | 0.030 |
Why?
|
| Acute Disease | 2 | 2019 | 7269 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1342 | 0.030 |
Why?
|
| Equipment Design | 2 | 2012 | 3520 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1337 | 0.030 |
Why?
|
| Alcoholism | 1 | 2004 | 1961 | 0.030 |
Why?
|
| Tanzania | 1 | 2018 | 1383 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2001 | 1174 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 2002 | 1142 | 0.030 |
Why?
|
| Xanthine | 1 | 2013 | 11 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22072 | 0.030 |
Why?
|
| Neuritis | 1 | 1993 | 36 | 0.030 |
Why?
|
| Neurofibromatosis 2 | 1 | 1997 | 385 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 314 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 3607 | 0.030 |
Why?
|
| Kidney Transplantation | 2 | 2004 | 4215 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 3 | 1999 | 7408 | 0.030 |
Why?
|
| Allergens | 1 | 2001 | 1402 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1602 | 0.030 |
Why?
|
| DNA | 2 | 2022 | 7233 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 664 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2011 | 4035 | 0.030 |
Why?
|
| Genes | 1 | 1997 | 1845 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 1900 | 0.030 |
Why?
|
| Sural Nerve | 1 | 1993 | 105 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2013 | 141 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 2138 | 0.030 |
Why?
|
| Retina | 3 | 1988 | 2635 | 0.030 |
Why?
|
| Phylogeny | 2 | 2016 | 2775 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1998 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 4810 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5305 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1810 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 1084 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 1992 | 6216 | 0.030 |
Why?
|
| Cell Communication | 1 | 2000 | 1653 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1992 | 31 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 877 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2014 | 534 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1992 | 55 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 558 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2012 | 299 | 0.030 |
Why?
|
| Synucleins | 2 | 2003 | 107 | 0.030 |
Why?
|
| Inosine | 1 | 2013 | 130 | 0.030 |
Why?
|
| Sex Factors | 3 | 2013 | 10547 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2012 | 28 | 0.030 |
Why?
|
| Interneurons | 1 | 2017 | 591 | 0.030 |
Why?
|
| Diagnosis | 1 | 2013 | 157 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1885 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 2011 | 185 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 1999 | 1066 | 0.020 |
Why?
|
| Organelle Size | 1 | 2011 | 6 | 0.020 |
Why?
|
| Neurologic Examination | 2 | 2010 | 916 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1067 | 0.020 |
Why?
|
| Cerebrovascular Trauma | 1 | 2011 | 22 | 0.020 |
Why?
|
| Sweden | 1 | 2015 | 1381 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 1356 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 3775 | 0.020 |
Why?
|
| Cognition | 2 | 2022 | 6957 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2203 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 9994 | 0.020 |
Why?
|
| Pulse Therapy, Drug | 1 | 2011 | 36 | 0.020 |
Why?
|
| World Health Organization | 1 | 2017 | 1312 | 0.020 |
Why?
|
| Cations | 1 | 1992 | 239 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2022 | 2981 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2012 | 516 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1992 | 1095 | 0.020 |
Why?
|
| Antibodies, Bacterial | 3 | 1999 | 1468 | 0.020 |
Why?
|
| Data Display | 1 | 2012 | 174 | 0.020 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1991 | 42 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 210 | 0.020 |
Why?
|
| Sheep | 1 | 1994 | 1441 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 1791 | 0.020 |
Why?
|
| Electroretinography | 1 | 2013 | 517 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2018 | 792 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 418 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1167 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 1992 | 246 | 0.020 |
Why?
|
| Visual Perception | 1 | 2019 | 1374 | 0.020 |
Why?
|
| Chloride Channels | 1 | 1992 | 221 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.020 |
Why?
|
| Abdomen | 1 | 1997 | 1130 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2011 | 617 | 0.020 |
Why?
|
| Infection Control | 1 | 2018 | 983 | 0.020 |
Why?
|
| Presenilin-2 | 2 | 2000 | 95 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2313 | 0.020 |
Why?
|
| Executive Function | 1 | 2019 | 1374 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3380 | 0.020 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 1433 | 0.020 |
Why?
|
| Polynucleotides | 1 | 1990 | 27 | 0.020 |
Why?
|
| Warfarin | 1 | 2019 | 1518 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 597 | 0.020 |
Why?
|
| Internet | 2 | 2001 | 3078 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2010 | 35 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2019 | 2488 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2012 | 301 | 0.020 |
Why?
|
| Oxalic Acid | 1 | 1989 | 20 | 0.020 |
Why?
|
| Blotting, Southern | 2 | 2001 | 777 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4490 | 0.020 |
Why?
|
| Pain Perception | 1 | 2011 | 196 | 0.020 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 1982 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 995 | 0.020 |
Why?
|
| Computer Communication Networks | 1 | 2012 | 294 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2011 | 2608 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1997 | 1183 | 0.020 |
Why?
|
| Thermodynamics | 2 | 1995 | 599 | 0.020 |
Why?
|
| Urogenital System | 1 | 1989 | 88 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 751 | 0.020 |
Why?
|
| Syndrome | 1 | 2016 | 3280 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1992 | 956 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1002 | 0.020 |
Why?
|
| Computational Biology | 1 | 2001 | 3505 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2176 | 0.020 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2009 | 54 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 71 | 0.020 |
Why?
|
| Pedigree | 2 | 2015 | 4578 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 492 | 0.020 |
Why?
|
| Oxalates | 1 | 1989 | 98 | 0.020 |
Why?
|
| Bacteremia | 1 | 1996 | 980 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 1913 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2860 | 0.020 |
Why?
|
| COS Cells | 2 | 2002 | 1129 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2009 | 73 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 848 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 884 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 6498 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 356 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1077 | 0.020 |
Why?
|
| Alanine | 1 | 2011 | 606 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1705 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 279 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2011 | 1869 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 551 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 1446 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2010 | 163 | 0.020 |
Why?
|
| Pregnancy | 3 | 2007 | 29749 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 256 | 0.020 |
Why?
|
| Macrophages | 3 | 2017 | 5745 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2009 | 419 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1588 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 313 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2514 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2011 | 396 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2020 | 65017 | 0.020 |
Why?
|
| Mecamylamine | 1 | 1988 | 27 | 0.020 |
Why?
|
| Peptide Library | 1 | 2009 | 347 | 0.020 |
Why?
|
| Tubocurarine | 1 | 1988 | 62 | 0.020 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 151 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 7021 | 0.020 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2008 | 26 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 617 | 0.020 |
Why?
|
| Prednisone | 1 | 1993 | 1565 | 0.020 |
Why?
|
| Insulin | 1 | 2003 | 6597 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2385 | 0.020 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2008 | 42 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2011 | 613 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3529 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2448 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1999 | 763 | 0.020 |
Why?
|
| Minocycline | 1 | 2009 | 168 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 3604 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2016 | 11481 | 0.020 |
Why?
|
| Atropine | 1 | 1988 | 245 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13630 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 1006 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 2583 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9073 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 1989 | 681 | 0.020 |
Why?
|
| Galactosylgalactosylglucosylceramidase | 1 | 2006 | 4 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3736 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1672 | 0.020 |
Why?
|
| Glaucoma | 1 | 2017 | 1182 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5725 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 1737 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 330 | 0.020 |
Why?
|
| Hamartoma | 1 | 2009 | 235 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2023 | 4642 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2864 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2057 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 2997 | 0.020 |
Why?
|
| Europe | 1 | 1994 | 3441 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2007 | 239 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2007 | 118 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1988 | 304 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1741 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 2003 | 1600 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 603 | 0.020 |
Why?
|
| Vibrissae | 1 | 2007 | 116 | 0.020 |
Why?
|
| Simvastatin | 1 | 2009 | 352 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 392 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Skin Window Technique | 1 | 2006 | 22 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2773 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 2234 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1988 | 881 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2007 | 123 | 0.020 |
Why?
|
| Glycosylation | 2 | 2001 | 1096 | 0.020 |
Why?
|
| Hyperemia | 1 | 2007 | 221 | 0.020 |
Why?
|
| Camptothecin | 1 | 2009 | 590 | 0.020 |
Why?
|
| Vision, Monocular | 1 | 2006 | 71 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2053 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2007 | 261 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2007 | 518 | 0.020 |
Why?
|
| Sepsis | 1 | 2000 | 2592 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2005 | 48 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 1868 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 1999 | 1085 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 663 | 0.020 |
Why?
|
| Virulence | 2 | 1999 | 1298 | 0.020 |
Why?
|
| United States | 4 | 2015 | 72461 | 0.020 |
Why?
|
| Kidney Calculi | 1 | 1989 | 468 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2919 | 0.020 |
Why?
|
| Glycine | 1 | 1988 | 662 | 0.020 |
Why?
|
| Geniculate Bodies | 1 | 2006 | 154 | 0.020 |
Why?
|
| Bacteria | 1 | 1996 | 2199 | 0.020 |
Why?
|
| Protease Nexins | 1 | 2004 | 39 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1998 | 856 | 0.020 |
Why?
|
| Cholesterol Esters | 1 | 2004 | 73 | 0.020 |
Why?
|
| Necrosis | 2 | 2001 | 1612 | 0.020 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2005 | 50 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 281 | 0.010 |
Why?
|
| Memory | 1 | 2014 | 2179 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2506 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1988 | 494 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2003 | 1949 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5325 | 0.010 |
Why?
|
| Hospitals | 1 | 2018 | 3928 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 707 | 0.010 |
Why?
|
| Carnosine | 1 | 1984 | 6 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2222 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4357 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2008 | 652 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1999 | 3763 | 0.010 |
Why?
|
| Comorbidity | 1 | 2019 | 10551 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2004 | 223 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1984 | 234 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3610 | 0.010 |
Why?
|
| Leucine | 1 | 2005 | 547 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 1878 | 0.010 |
Why?
|
| Vasodilation | 1 | 2007 | 962 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2010 | 2253 | 0.010 |
Why?
|
| Amphotericin B | 1 | 2003 | 142 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10182 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2004 | 311 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3602 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2006 | 567 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3539 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16939 | 0.010 |
Why?
|
| Methionine | 1 | 2005 | 569 | 0.010 |
Why?
|
| Microsurgery | 1 | 1988 | 796 | 0.010 |
Why?
|
| Phenanthrolines | 1 | 2002 | 51 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2002 | 154 | 0.010 |
Why?
|
| RNA | 1 | 2012 | 2722 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 2001 | 25 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5877 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 2003 | 234 | 0.010 |
Why?
|
| Patient Selection | 1 | 2014 | 4283 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 419 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2009 | 2668 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2004 | 554 | 0.010 |
Why?
|
| Microinjections | 2 | 1993 | 321 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2002 | 508 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 2001 | 39 | 0.010 |
Why?
|
| Amino Acids | 1 | 1988 | 1714 | 0.010 |
Why?
|
| Echinocandins | 1 | 2001 | 51 | 0.010 |
Why?
|
| Colombia | 1 | 2002 | 276 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 2001 | 77 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 2001 | 62 | 0.010 |
Why?
|
| Lipopeptides | 1 | 2001 | 72 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4373 | 0.010 |
Why?
|
| Reflex, Pupillary | 1 | 2001 | 58 | 0.010 |
Why?
|
| Putaminal Hemorrhage | 1 | 2001 | 5 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 557 | 0.010 |
Why?
|
| Craniotomy | 1 | 2006 | 741 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 548 | 0.010 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2001 | 111 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 2001 | 69 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2924 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5201 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 2002 | 246 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1988 | 1089 | 0.010 |
Why?
|
| Antigens, Plant | 1 | 2001 | 104 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 1234 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2000 | 91 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 665 | 0.010 |
Why?
|
| Glycerophospholipids | 1 | 2000 | 39 | 0.010 |
Why?
|
| Calcium Channels, N-Type | 1 | 2000 | 43 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2000 | 74 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2010 | 1977 | 0.010 |
Why?
|
| Freezing | 1 | 2001 | 306 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2001 | 313 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2852 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 666 | 0.010 |
Why?
|
| Sphingomyelins | 1 | 2000 | 103 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2001 | 231 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3800 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1989 | 1801 | 0.010 |
Why?
|
| Sorbitol | 1 | 1999 | 56 | 0.010 |
Why?
|
| O Antigens | 1 | 2001 | 196 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9631 | 0.010 |
Why?
|
| Gangliosides | 1 | 2000 | 131 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 663 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1175 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 1999 | 40 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 1999 | 57 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 887 | 0.010 |
Why?
|
| Dopamine | 1 | 2007 | 1595 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2005 | 865 | 0.010 |
Why?
|
| Abscess | 1 | 2003 | 605 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 900 | 0.010 |
Why?
|
| Ion Transport | 1 | 2000 | 318 | 0.010 |
Why?
|
| Phalloidine | 1 | 1999 | 21 | 0.010 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1999 | 20 | 0.010 |
Why?
|
| Fermentation | 1 | 1999 | 146 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 751 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6218 | 0.010 |
Why?
|
| Shiga Toxin 1 | 1 | 1998 | 42 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2000 | 240 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 580 | 0.010 |
Why?
|
| Protozoan Proteins | 1 | 2005 | 839 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1999 | 110 | 0.010 |
Why?
|
| Picrotoxin | 2 | 1988 | 62 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1998 | 89 | 0.010 |
Why?
|
| Arginine | 1 | 2002 | 934 | 0.010 |
Why?
|
| Candida albicans | 1 | 2001 | 374 | 0.010 |
Why?
|
| Microvilli | 1 | 1999 | 233 | 0.010 |
Why?
|
| Acetylation | 1 | 2001 | 1062 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 511 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1999 | 257 | 0.010 |
Why?
|
| Pseudopodia | 1 | 1999 | 168 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2011 | 8555 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1998 | 151 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 1999 | 394 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 891 | 0.010 |
Why?
|
| Gallbladder | 1 | 1999 | 305 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2000 | 932 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2221 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2000 | 383 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 2557 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 2116 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 489 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1984 | 1036 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 689 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 1866 | 0.010 |
Why?
|
| Cysteine | 1 | 2002 | 895 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1999 | 218 | 0.010 |
Why?
|
| E-Selectin | 1 | 1999 | 576 | 0.010 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1999 | 354 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1999 | 410 | 0.010 |
Why?
|
| Kidney | 2 | 1995 | 7064 | 0.010 |
Why?
|
| Staphylococcal Protein A | 1 | 1996 | 39 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2001 | 565 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1792 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 694 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1998 | 365 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 393 | 0.010 |
Why?
|
| Hemolysis | 1 | 1999 | 423 | 0.010 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1996 | 122 | 0.010 |
Why?
|
| Clone Cells | 1 | 2000 | 1660 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2006 | 1879 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 1999 | 495 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 3084 | 0.010 |
Why?
|
| Cell Division | 1 | 1984 | 4463 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1999 | 782 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 1998 | 325 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2873 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 1993 | 2316 | 0.010 |
Why?
|
| Brain Stem | 1 | 2001 | 857 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1995 | 67 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3442 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1999 | 598 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 839 | 0.010 |
Why?
|
| Haptens | 1 | 1995 | 163 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1999 | 740 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 788 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1535 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2002 | 1296 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5791 | 0.010 |
Why?
|
| Catalysis | 1 | 1996 | 775 | 0.010 |
Why?
|
| Learning | 1 | 2004 | 1739 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1995 | 337 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 4773 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2698 | 0.010 |
Why?
|
| Cadherins | 1 | 1999 | 898 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1995 | 346 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 4925 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2002 | 26181 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6131 | 0.010 |
Why?
|
| Imidazoles | 1 | 2000 | 1180 | 0.010 |
Why?
|
| Crystallization | 1 | 1995 | 533 | 0.010 |
Why?
|
| Thiophenes | 1 | 1998 | 587 | 0.010 |
Why?
|
| beta Catenin | 1 | 1999 | 1043 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3334 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2000 | 1268 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1995 | 465 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1999 | 1207 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1543 | 0.010 |
Why?
|
| Cerebellum | 1 | 2000 | 1496 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2002 | 1385 | 0.010 |
Why?
|
| Lysosomes | 1 | 1998 | 920 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 1931 | 0.010 |
Why?
|
| Methylation | 1 | 1995 | 1082 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21392 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 3105 | 0.010 |
Why?
|
| Pia Mater | 1 | 1992 | 87 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2659 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Macaca nemestrina | 1 | 1991 | 21 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1992 | 700 | 0.010 |
Why?
|
| Actins | 1 | 1999 | 2049 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 2912 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 221 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1995 | 1387 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 2250 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1993 | 498 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 283 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1999 | 1313 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 613 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 3765 | 0.010 |
Why?
|
| Hypertension | 1 | 2010 | 8594 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1407 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1990 | 814 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1997 | 1266 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 534 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2000 | 2821 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1990 | 245 | 0.010 |
Why?
|
| Strychnine | 1 | 1988 | 34 | 0.010 |
Why?
|
| Rural Population | 1 | 1999 | 2268 | 0.010 |
Why?
|
| Bicuculline | 1 | 1988 | 96 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2003 | 6381 | 0.000 |
Why?
|
| Receptors, Amino Acid | 1 | 1988 | 30 | 0.000 |
Why?
|
| Taurine | 1 | 1988 | 93 | 0.000 |
Why?
|
| Neutrophils | 1 | 1999 | 3767 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 11152 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 2094 | 0.000 |
Why?
|
| Antigens | 1 | 1990 | 1447 | 0.000 |
Why?
|
| DNA Replication | 1 | 1991 | 1412 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1997 | 9287 | 0.000 |
Why?
|